Gene: SLC25A43
Official Full Name: solute carrier family 25 member 43provided by HGNC
Gene Summary: This gene encodes a member of the mitochondrial carrier family of proteins.[provided by RefSeq, Dec 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35928 | SLC25A43 Knockout cell line (HeLa) | Human | SLC25A43 | 1:3~1:6 | Negative | Online Inquiry |
KO35929 | SLC25A43 Knockout cell line (HCT 116) | Human | SLC25A43 | 1:2~1:4 | Negative | Online Inquiry |
KO35930 | SLC25A43 Knockout cell line (HEK293) | Human | SLC25A43 | 1:3~1:6 | Negative | Online Inquiry |
KO35931 | SLC25A43 Knockout cell line (A549) | Human | SLC25A43 | 1:3~1:4 | Negative | Online Inquiry |
SLC25A43 Gene Knockout Cell Lines are specialized cellular models engineered to lack the SLC25A43 gene, which encodes for a mitochondrial carrier protein involved in transporting metabolites across the mitochondrial membrane. These knockout cell lines serve as vital tools for studying the gene's functions in cellular metabolism, energy production, and overall mitochondrial physiology. By examining the consequences of SLC25A43 deletion, researchers can elucidate its role in important biological processes, including apoptosis, cell growth, and the response to metabolic stress.
The mechanism of action hinges on the disruption of SLC25A43, leading to altered mitochondrial transport and subsequent changes in cellular biochemistry. This can manifest in variations in ATP production, reactive oxygen species (ROS) generation, and metabolic flux within the cell, making these cell lines ideal for investigating the downstream effects of SLC25A43 deficiency. In both research and clinical settings, understanding these mechanisms can significantly advance knowledge of metabolic diseases and mitochondrial dysfunctions.
One of the distinct advantages of using SLC25A43 Gene Knockout Cell Lines lies in their specificity; they allow for targeted studies that alternative models cannot achieve. Unlike pharmacological inhibitors or temporary knockdowns, these stable knockout lines provide a consistent background for experimentation, resulting in high reproducibility of results. Furthermore, researchers can utilize these models to develop new therapeutic strategies for diseases linked to mitochondrial dysfunction, potentially translating findings into clinical applications.
The value of SLC25A43 Gene Knockout Cell Lines is strengthened by their potential to uncover novel insights into mitochondrial biology, making them indispensable for both academic and industrial research pursuits. By employing these models, researchers, clinicians, and pharmacologists can identify new biomarkers and therapeutic targets, significantly impacting the field of cellular metabolism.
Our company specializes in providing high-quality biological products tailored to facilitate groundbreaking research. With a commitment to advancing scientific knowledge and offering exceptional support, we ensure that our clients have access to cutting-edge tools like the SLC25A43 Gene Knockout Cell Lines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.